Dr. Reddy's Laboratories
RDY
#1699
Rank
NZ$20.54 B
Marketcap
NZ$24.56
Share price
0.35%
Change (1 day)
0.48%
Change (1 year)

Market capitalization of Dr. Reddy's Laboratories (RDY)

Market cap: NZ$20.54 Billion

As of December 2025 Dr. Reddy's Laboratories has a market cap of NZ$20.54 Billion. This makes Dr. Reddy's Laboratories the world's 1699th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dr. Reddy's Laboratories from 2001 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$20.54 B-13.94%
2024NZ$23.87 B29.43%
2023NZ$18.44 B36.27%
2022NZ$13.53 B-15.52%
2021NZ$16.02 B-1.66%
2020NZ$16.29 B64.63%
2019NZ$9.89 B6.97%
2018NZ$9.25 B5.1%
2017NZ$8.80 B-18.27%
2016NZ$10.77 B-7.42%
2015NZ$11.63 B4.56%
2014NZ$11.12 B31.16%
2013NZ$8.48 B23.07%
2012NZ$6.89 B6.69%
2011NZ$6.46 B-20.55%
2010NZ$8.13 B42.21%
2009NZ$5.71 B103.97%
2008NZ$2.80 B-29.66%
2007NZ$3.98 B-8.06%
2006NZ$4.33 B79.3%
2005NZ$2.41 B13.72%
2004NZ$2.12 B-42.92%
2003NZ$3.72 B31.82%
2002NZ$2.82 B-19.06%
2001NZ$3.49 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Dr. Reddy's Laboratories was reported to be:

NZ$20.50 Billion
by Nasdaq info icon info icon
NZ$20.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$256.18 B 1,146.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.52 B 175.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$169.15 B 723.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$438.96 B 2,036.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$209.27 B 918.63%๐Ÿ‡ซ๐Ÿ‡ท France